The Geneva Foundation
The Geneva Foundation advances military medicine through research, development, and education, focusing on innovative solutions to improve the health, readiness, and capabilities of service members and the communities they serve. With a history of over 25 years, Geneva collaborates across government, industry, and academia to deliver impactful research and medical solutions, emphasizing ethics, scientific standards, and strategic partnerships.
Industries
Nr. of Employees
large (251-1000)
The Geneva Foundation
6700-A Rockledge Dr, Suite 510, Bethesda, MD 20817
Products
Bioprinting and biofabrication center (research program and facility)
A research and training center focused on bioprinting, biofabrication, biomanufacturing, and point‑of‑care biotechnology development and translation.
On‑demand blood product development program
Program to develop methods and infrastructure for producing transfusion‑ready red blood cells and related products onsite to enable transfusion in austere environments.
Tele‑critical care network implementation and support
Implementation and operational support for networked tele‑critical care services to extend expert critical care guidance to bedside providers using networked mobile devices.
Clinical studies of AI‑enabled handheld ultrasound
Clinical acquisition and algorithm development program for handheld ultrasound imaging with real‑time machine learning analysis to support rapid triage of lung and trauma injuries.
Smartphone‑based mental health application (multimedia coping and self‑help tools)
A multimedia mobile application delivering personalized coping tools, distraction and relaxation exercises, activity planning, inspirational content, and support contact management; developed and evaluated in partnership with military and veterans' health organizations and assessed in clinical trials.
Bioprinting and biofabrication center (research program and facility)
A research and training center focused on bioprinting, biofabrication, biomanufacturing, and point‑of‑care biotechnology development and translation.
On‑demand blood product development program
Program to develop methods and infrastructure for producing transfusion‑ready red blood cells and related products onsite to enable transfusion in austere environments.
Tele‑critical care network implementation and support
Implementation and operational support for networked tele‑critical care services to extend expert critical care guidance to bedside providers using networked mobile devices.
Clinical studies of AI‑enabled handheld ultrasound
Clinical acquisition and algorithm development program for handheld ultrasound imaging with real‑time machine learning analysis to support rapid triage of lung and trauma injuries.
Smartphone‑based mental health application (multimedia coping and self‑help tools)
A multimedia mobile application delivering personalized coping tools, distraction and relaxation exercises, activity planning, inspirational content, and support contact management; developed and evaluated in partnership with military and veterans' health organizations and assessed in clinical trials.
Services
End‑to‑end management of federally and industry funded research programs, including cooperative agreements, consortia, subawards, and award administration.
Technical writing, budget development, and proposal strategy to prepare competitive grant and contract submissions.
Regulatory planning and preparation for investigational and premarket submission pathways to support product development and clinical translation.
Technology transfer, patentability assessment, licensing strategy, and commercialization planning to translate research into marketable products.
Clinical data capture, database management, and analytic services to support trials, observational studies, and biomarker research.
Recruiting, hiring, and management of research personnel including coordinators, technicians, and clinical staff to support study operations.
End‑to‑end management of federally and industry funded research programs, including cooperative agreements, consortia, subawards, and award administration.
Technical writing, budget development, and proposal strategy to prepare competitive grant and contract submissions.
Regulatory planning and preparation for investigational and premarket submission pathways to support product development and clinical translation.
Technology transfer, patentability assessment, licensing strategy, and commercialization planning to translate research into marketable products.
Clinical data capture, database management, and analytic services to support trials, observational studies, and biomarker research.
Recruiting, hiring, and management of research personnel including coordinators, technicians, and clinical staff to support study operations.
Expertise Areas
- Clinical trial management
- Biotechnology and biomanufacturing
- Vaccine and antibody therapeutics
- Infectious disease research
Key Technologies
- 3D bioprinting and biofabrication
- Bioreactors and tissue culture systems
- Functional near‑infrared spectroscopy (fNIRS)
- Electroencephalography (EEG)
News & Updates
Development of AI-powered handheld ultrasound devices for rapid diagnosis in trauma and mass casualty events, supported by Geneva in collaboration with Philips and OHSU.
Research by University of Maryland and Geneva uncovers novel immune response in malaria, with implications for vaccines and treatments.
Development of fNIRS technology to assess brain activity and glymphatic function during sleep, led by LCDR J. Kent Werner.
Evaluation of virtual reality exposure therapy for combat-related PTSD, supported by Geneva and the U.S. Army.
Research on COVID-19 vaccine efficacy among service members, contributing to military health strategies.
Geneva collaborates on infectious disease research, including COVID-19, Ebola, dengue, chikungunya, Lassa fever, Sudan virus, malaria, Marburg, and hemorrhagic fever, aiming to develop vaccines and countermeasures.
Development of AI-powered handheld ultrasound devices for rapid diagnosis in trauma and mass casualty events, supported by Geneva in collaboration with Philips and OHSU.
Research by University of Maryland and Geneva uncovers novel immune response in malaria, with implications for vaccines and treatments.
Development of fNIRS technology to assess brain activity and glymphatic function during sleep, led by LCDR J. Kent Werner.
Evaluation of virtual reality exposure therapy for combat-related PTSD, supported by Geneva and the U.S. Army.
Research on COVID-19 vaccine efficacy among service members, contributing to military health strategies.
Geneva collaborates on infectious disease research, including COVID-19, Ebola, dengue, chikungunya, Lassa fever, Sudan virus, malaria, Marburg, and hemorrhagic fever, aiming to develop vaccines and countermeasures.